Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 5:02 pm Unchanged | 2021-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | VIKING GLOBAL INVESTORS LP | 29,993,708 21.300% | 0 (Unchanged) | Filing History |
| 2022-02-14 12:05 pm Sale | 2021-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | Matrix Capital Management Company LP | 11,572,590 8.200% | -1,542,500 (-11.76%) | Filing History |
| 2022-02-10 1:16 pm Purchase | 2022-01-31 | 13G | Adaptive Biotechnologies Corporation ADPT | T. Rowe Price Associates, Inc. | 14,240,614 10.000% | 953,901 (+7.18%) | Filing History |
| 2022-02-10 1:13 pm Purchase | 2021-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | T. Rowe Price Associates, Inc. | 13,286,713 9.400% | 13,286,713 (New Position) | Filing History |
| 2022-02-09 3:16 pm Purchase | 2021-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | The Vanguard Group | 11,031,288 7.820% | 1,375,863 (+14.25%) | Filing History |
| 2021-02-16 10:01 am Sale | 2020-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | Matrix Capital Management Company LP | 13,115,090 9.590% | -4,217,101 (-24.33%) | Filing History |
| 2021-02-12 7:38 pm Sale | 2020-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | VIKING GLOBAL INVESTORS LP | 29,993,708 21.900% | -8,412,899 (-21.90%) | Filing History |
| 2021-02-10 10:30 am Purchase | 2020-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | The Vanguard Group | 9,655,425 7.060% | 9,655,425 (New Position) | Filing History |